nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CHRM4—nervous system—attention deficit hyperactivity disorder	0.00834	0.0537	CbGeAlD
Tolterodine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00825	0.0531	CbGeAlD
Tolterodine—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.00803	0.0517	CbGeAlD
Tolterodine—CHRM1—forebrain—attention deficit hyperactivity disorder	0.0075	0.0483	CbGeAlD
Tolterodine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00697	0.0449	CbGeAlD
Tolterodine—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00672	0.0433	CbGeAlD
Tolterodine—CHRM5—nervous system—attention deficit hyperactivity disorder	0.00652	0.042	CbGeAlD
Tolterodine—CHRM4—brain—attention deficit hyperactivity disorder	0.00638	0.0411	CbGeAlD
Tolterodine—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00635	0.0409	CbGeAlD
Tolterodine—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.00628	0.0404	CbGeAlD
Tolterodine—KCNH2—forebrain—attention deficit hyperactivity disorder	0.00596	0.0384	CbGeAlD
Tolterodine—Chlorphenamine—SLC6A3—attention deficit hyperactivity disorder	0.00511	0.216	CrCbGaD
Tolterodine—KCNH2—cardiovascular system—attention deficit hyperactivity disorder	0.00504	0.0324	CbGeAlD
Tolterodine—CHRM5—brain—attention deficit hyperactivity disorder	0.00498	0.0321	CbGeAlD
Tolterodine—Atomoxetine—HTR1B—attention deficit hyperactivity disorder	0.00475	0.201	CrCbGaD
Tolterodine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00448	0.0288	CbGeAlD
Tolterodine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00431	0.0278	CbGeAlD
Tolterodine—Atomoxetine—SLC6A3—attention deficit hyperactivity disorder	0.00429	0.182	CrCbGaD
Tolterodine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00409	0.0264	CbGeAlD
Tolterodine—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00407	0.0262	CbGeAlD
Tolterodine—KCNH2—midbrain—attention deficit hyperactivity disorder	0.00393	0.0253	CbGeAlD
Tolterodine—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00392	0.0253	CbGeAlD
Tolterodine—Chlorphenamine—SLC6A4—attention deficit hyperactivity disorder	0.00382	0.162	CrCbGaD
Tolterodine—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00365	0.0235	CbGeAlD
Tolterodine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00363	0.0234	CbGeAlD
Tolterodine—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00351	0.0226	CbGeAlD
Tolterodine—CHRM2—brain—attention deficit hyperactivity disorder	0.00342	0.022	CbGeAlD
Tolterodine—KCNH2—nervous system—attention deficit hyperactivity disorder	0.00323	0.0208	CbGeAlD
Tolterodine—Atomoxetine—SLC6A4—attention deficit hyperactivity disorder	0.00321	0.136	CrCbGaD
Tolterodine—CHRM1—brain—attention deficit hyperactivity disorder	0.00311	0.0201	CbGeAlD
Tolterodine—KCNH2—central nervous system—attention deficit hyperactivity disorder	0.00311	0.02	CbGeAlD
Tolterodine—KCNH2—cerebellum—attention deficit hyperactivity disorder	0.00304	0.0196	CbGeAlD
Tolterodine—CHRM3—brain—attention deficit hyperactivity disorder	0.00279	0.0179	CbGeAlD
Tolterodine—KCNH2—brain—attention deficit hyperactivity disorder	0.00247	0.0159	CbGeAlD
Tolterodine—Atomoxetine—HTR2A—attention deficit hyperactivity disorder	0.00247	0.104	CrCbGaD
Tolterodine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.002	0.0129	CbGeAlD
Tolterodine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00197	0.0127	CbGeAlD
Tolterodine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00193	0.0124	CbGeAlD
Tolterodine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.0019	0.0122	CbGeAlD
Tolterodine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00186	0.0119	CbGeAlD
Tolterodine—CYP2D6—brain—attention deficit hyperactivity disorder	0.00151	0.00971	CbGeAlD
Tolterodine—CHRM4—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000546	0.000666	CbGpPWpGaD
Tolterodine—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000544	0.000663	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000543	0.000661	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000541	0.000659	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000536	0.000652	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000532	0.000647	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00053	0.000645	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00053	0.000645	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000528	0.000643	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000525	0.000639	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000523	0.000637	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000523	0.000637	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000513	0.000625	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000512	0.000623	CbGpPWpGaD
Tolterodine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000507	0.000618	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000507	0.000617	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000504	0.000614	CbGpPWpGaD
Tolterodine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000504	0.000614	CbGpPWpGaD
Tolterodine—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000503	0.000613	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000503	0.000612	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000502	0.000612	CbGpPWpGaD
Tolterodine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0005	0.000609	CbGpPWpGaD
Tolterodine—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000499	0.000608	CbGpPWpGaD
Tolterodine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000498	0.000607	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000498	0.000607	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000498	0.000606	CbGpPWpGaD
Tolterodine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000497	0.000605	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000497	0.000605	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000496	0.000604	CbGpPWpGaD
Tolterodine—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000496	0.000604	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000493	0.0006	CbGpPWpGaD
Tolterodine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000492	0.000599	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000492	0.000599	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000491	0.000598	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000486	0.000592	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000483	0.000588	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000482	0.000587	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000481	0.000586	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000481	0.000586	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000478	0.000582	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000477	0.00058	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000475	0.000579	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000464	0.000565	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000463	0.000563	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000462	0.000562	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000458	0.000558	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000457	0.000557	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000444	0.000541	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000434	0.000529	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000434	0.000528	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000433	0.000527	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000432	0.000526	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00043	0.000524	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000428	0.000522	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000427	0.00052	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000425	0.000518	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000425	0.000518	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000423	0.000515	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000423	0.000515	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000421	0.000513	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000418	0.000508	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000415	0.000506	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000415	0.000505	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000413	0.000503	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000412	0.000502	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000405	0.000493	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000405	0.000493	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000403	0.000491	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.0004	0.000487	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000397	0.000484	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000391	0.000476	CbGpPWpGaD
Tolterodine—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00039	0.000475	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000389	0.000474	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000386	0.00047	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000384	0.000468	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000379	0.000462	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000374	0.000455	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000372	0.000454	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000368	0.000449	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000368	0.000448	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000367	0.000447	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000364	0.000443	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000363	0.000442	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000353	0.00043	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000347	0.000423	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000339	0.000413	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000338	0.000412	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000338	0.000411	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000335	0.000408	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000334	0.000407	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000334	0.000406	CbGpPWpGaD
Tolterodine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000332	0.000404	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00033	0.000402	CbGpPWpGaD
Tolterodine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000329	0.000401	CbGpPWpGaD
Tolterodine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000327	0.000398	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000325	0.000396	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000324	0.000395	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000322	0.000392	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000322	0.000392	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000321	0.000391	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000321	0.000391	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000318	0.000387	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000299	0.000365	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000298	0.000363	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000296	0.00036	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000293	0.000357	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000292	0.000356	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000292	0.000355	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000291	0.000355	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00029	0.000353	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00029	0.000353	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000289	0.000352	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000289	0.000352	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000287	0.00035	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000286	0.000349	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000285	0.000347	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000285	0.000347	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000284	0.000346	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000284	0.000346	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000282	0.000343	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000282	0.000343	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000281	0.000343	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000281	0.000342	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000281	0.000342	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00028	0.000341	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000279	0.00034	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000278	0.000338	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000276	0.000336	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000272	0.000332	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000272	0.000331	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000271	0.00033	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000268	0.000327	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000263	0.000321	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000262	0.00032	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000262	0.000319	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000261	0.000318	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000261	0.000318	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00026	0.000317	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000259	0.000315	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000259	0.000315	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000258	0.000314	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000256	0.000312	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000256	0.000311	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000256	0.000311	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000255	0.00031	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000252	0.000307	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000247	0.000301	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000245	0.000299	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00024	0.000292	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00024	0.000292	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000238	0.00029	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000238	0.00029	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000237	0.000289	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000237	0.000289	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000236	0.000287	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000235	0.000286	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000231	0.000281	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000228	0.000278	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000227	0.000276	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000226	0.000275	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000224	0.000273	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000221	0.000269	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000219	0.000267	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000217	0.000264	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000214	0.000261	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000209	0.000254	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000207	0.000253	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000206	0.000251	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.0002	0.000243	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000198	0.000241	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000197	0.00024	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000195	0.000238	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000191	0.000233	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000184	0.000224	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000183	0.000223	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000182	0.000222	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000181	0.000221	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000173	0.00021	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000172	0.00021	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000171	0.000208	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000167	0.000203	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000166	0.000202	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000165	0.000201	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000161	0.000196	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00016	0.000195	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000159	0.000193	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000156	0.00019	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000156	0.00019	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000156	0.000189	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000155	0.000189	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000154	0.000187	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000153	0.000187	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000153	0.000186	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000152	0.000186	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000151	0.000184	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000151	0.000184	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000151	0.000183	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000149	0.000182	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000146	0.000178	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000145	0.000177	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000144	0.000175	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000143	0.000174	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000143	0.000174	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000142	0.000173	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000142	0.000173	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000142	0.000173	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000141	0.000172	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000141	0.000171	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00014	0.000171	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00014	0.00017	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00014	0.00017	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000139	0.000169	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000136	0.000165	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000131	0.00016	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00013	0.000158	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000124	0.000152	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000119	0.000144	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000114	0.000139	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000114	0.000138	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000109	0.000133	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000108	0.000132	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.85e-05	0.00012	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.82e-05	0.00012	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.73e-05	0.000118	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	9.43e-05	0.000115	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	9.37e-05	0.000114	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	9.36e-05	0.000114	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.36e-05	0.000114	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	9.21e-05	0.000112	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	9.08e-05	0.000111	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	8.68e-05	0.000106	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	8.62e-05	0.000105	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	8.6e-05	0.000105	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.56e-05	0.000104	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	8.54e-05	0.000104	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.28e-05	0.000101	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.74e-05	9.43e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.49e-05	9.12e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.41e-05	9.03e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.13e-05	8.68e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	6.22e-05	7.58e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	5.67e-05	6.91e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	5.63e-05	6.86e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.22e-05	6.36e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.2e-05	6.34e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.15e-05	6.28e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	4.05e-05	4.93e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	3.72e-05	4.53e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	3.69e-05	4.49e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.43e-05	2.96e-05	CbGpPWpGaD
